Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
AACR Annual meetingAACR Annual meeting
Not Confirmed
Not Confirmed
25-30 April, 2025
AOCS Annual MeetingAOCS Annual Meeting
Not Confirmed
Not Confirmed
27-30 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
AACR Annual meetingAACR Annual meeting
Industry Trade Show
Not Confirmed
25-30 April, 2025
AOCS Annual MeetingAOCS Annual Meeting
Industry Trade Show
Not Confirmed
27-30 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels
23 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/934562/sabinsa-and-postbiotics-inc-announce-a-multinational-distribution-agreement-for-the-postbiotic-dietary-supplement-ingredient-pozibio
21 Oct 2024
// EXPRESSPHARMA
https://www.expresspharma.in/shaheen-majeed-elected-as-vice-chairman-of-cii-ip/
Details:
The distribution agreement aims for the dietary supplement and functional food ingredient PoZibio for age-related digestive health conditions including Leaky Gut Syndrome (LGS).
Lead Product(s): Lactobacillus Paracasei
Therapeutic Area: Gastroenterology Brand Name: PoZibio
Study Phase: Approved FDFProduct Type: Other Large Molecule
Sponsor: Postbiotics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement October 23, 2024
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Postbiotics
Deal Size : Undisclosed
Deal Type : Agreement
Sabinsa And Postbiotics Ink Deal for PoZibio Dietary Supplement
Details : The distribution agreement aims for the dietary supplement and functional food ingredient PoZibio for age-related digestive health conditions including Leaky Gut Syndrome (LGS).
Product Name : PoZibio
Product Type : Other Large Molecule
Upfront Cash : Undisclosed
October 23, 2024
ABOUT THIS PAGE
Sami-Sabinsa Group is a supplier offers 5 products (APIs, Excipients or Intermediates).
Find a price of 672-15-1 bulk offered by Sami-Sabinsa Group
Find a price of Cotinine bulk offered by Sami-Sabinsa Group
Find a price of Pyridostigmine bulk offered by Sami-Sabinsa Group
Find a price of Selenium Methionine bulk offered by Sami-Sabinsa Group
Find a price of Thalidomide bulk offered by Sami-Sabinsa Group